Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
TMPRSS13 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TMPRSS13 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of TMPRSS13 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
TMPRSS11D Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TMPRSS11D Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of TMPRSS11D sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
TMPRSS11E Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TMPRSS11E Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of TMPRSS11E sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
TMPRSS11F Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TMPRSS11F Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of TMPRSS11F sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
TMC2 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TMC2 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of TMC2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
TMC8 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TMC8 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of TMC8 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
TMPRSS11B Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TMPRSS11B Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of TMPRSS11B sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
TMPRSS11A Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TMPRSS11A Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of TMPRSS11A sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
TMC6 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TMC6 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of TMC6 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
SPG7 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
SPG7 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of SPG7 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
THY1 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
THY1 Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of THY1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PKDCC Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PKDCC Biologics Sequence Review Report 2026: Similarity and Patent-Risk Signals
16 October 2026
A Biology Modality MCP review of PKDCC sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →